FDA to hand controversial diet drug support look
On Wednesday, it takes a back up look next to a drug called Qnexa, a combination of the drugs phentermine, a pick-me-up, and topiramate, a seizure otherwise migraine medication. Panel to muse outcome of Qnexa weight-loss pill Dr. Judith Korner, director of Columbia Universitys substance Control pivot, whispered the drug, according to the largely contemporary year-long study, helped fill lose 14.4 percent of their body burden. The statistic is based on in rank provided by Vivus Inc., the maker of the controversial drug.